Physician profile
James C Lin
NPI 1881696375
$6,575.19
in general payments reported to CMS, 2019-2025
24 companies · $369 in 2025
The $369 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $621 · 2020: $151 · 2021: $4,501 · 2022: $521 · 2023: $226 · 2024: $186 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $781.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $780.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,150.00 | 2021 | |
| Teleflex LLC | $858.85 | 2021-2024 | Urolift |
| Neotract INC. | $358.03 | 2019-2020 | |
| Astellas Pharma US INC | $224.56 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $133.05 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $103.75 | 2025 | Erleada |
| Procept Biorobotics Corporation | $82.54 | 2019 | |
| Dendreon Pharmaceuticals LLC | $81.26 | 2019 | |
| Abbvie INC. | $77.29 | 2023-2025 | |
| Accord Healthcare, INC. | $75.50 | 2024-2025 | |
| Endo USA, INC. | $70.51 | 2024-2025 | Xiaflex, Aveed |
| 180 Medical, INC. | $52.53 | 2019-2024 | Gentlecath |
| Endo Pharmaceuticals INC. | $37.75 | 2019 | |
| Coloplast Corp | $37.67 | 2020-2025 | |
| Boston Scientific Corporation | $37.53 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Calyxo, INC. | $30.90 | 2025 | Cvac Aspiration System |
| Pfizer INC. | $27.76 | 2019-2020 | |
| Palette Life Sciences, INC. | $26.96 | 2023 | |
| C. R. Bard, INC. & Subsidiaries | $24.27 | 2019 | |
| Karl Storz Endoscopy-America | $20.95 | 2019 | |
| Cook Medical LLC | $20.45 | 2024 | Roadrunner |
| Tolmar Pharmaceuticals, INC. | $17.24 | 2019 | |
| Smith+Nephew, INC. | $14.29 | 2020 | |
| Genentech USA, INC. | $11.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.